CompanyDigital

Baidu Health’s Precision Matching Engine Powers Public Hospitals

Company

WuXi Biologics’ Revenues Surge 63.5% in H1 2022 on Strong CRDMO Growth

CompanyDeals

MingMed Biotech’s Hong Kong IPO Signals Push for First-in-Class Drugs

CompanyDrug

Junshi Biosciences’ JunMaiKang Biosimilar Gets NMPA Approval Filing

CompanyDeals

Applied Protein Technology Raises Hundreds of Millions in Series B Funding

CompanyDeals

SciClone Licenses Menarini’s Vaborem to Tackle Drug-Resistant Infections in China

CompanyDrug

Zelgen Biopharmaceuticals’ ZGGS18 Receives NMPA Approval for Solid Tumor Treatment

CompanyDeals

Fortune Care Raises Hundreds of Millions in Series B for Elderly Care Expansion

Medical Device

Bio-Heart’s BIOHEART-II Study Meets Primary Endpoint for Bioresorbable Scaffolds

Company

Sihuan Pharmaceutical Restructures with Dual Organization Model

CompanyDeals

Baheal Pharmaceutical Partners with Takeda to Boost Drug Commercialization in China

CompanyDrug

Belief-Delivery BioMed’s BBM-H901 Granted BTD for Hemophilia B Prevention